Modulation of macrophage metabolism and function by the helminth peptide FhHDM-1

Publication Type:
Thesis
Issue Date:
2023
Full metadata record
Parasitic worms have evolved sophisticated strategies to regulate their host’s immune response, to prevent expulsion and establish chronic infections. Understanding how they achieve this offers a therapeutic strategy for the treatment of human diseases which are caused by unregulated inflammation. Previous characterisation of the liver fluke’s secreted proteins identified a peptide (termed FhHDM-1) that inhibited progression of immune-mediated disease in murine models of diabetes, multiple sclerosis and asthma. The aim of this PhD project was to uncover the mechanisms by which FhHDM-1 was mediating this beneficial effect. The research discovered that FhHDM-1 peptide regulates inflammation by reprogramming macrophage metabolism. Specifically, FhHDM-1 switched macrophages to a dependence on oxidative phosphorylation fuelled by fatty acids and supported by the induction of glutaminolysis. These changes mediated a decrease in glycolytic flux which consequently reduced pro-inflammatory cytokine production. This regulation of macrophage metabolism was maintained in vivo and furthermore, led to the reduction of histone methylation in bone marrow derived macrophages. This discovery suggests that FhHDM-1 can uniquely regulate the trained immune response; a phenotype of immune memory that underpins human immune-mediated diseases. Thus, this PhD project has unveiled a new paradigm of innate immune regulation, that explains the therapeutic efficacy of FhHDM-1.
Please use this identifier to cite or link to this item: